Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIOX
3276
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $3.93M | ﹤0.01% |
631,232
+414,982
| +192% | +$3.16M |
|
3277
CALL
Dick's Sporting Goods
DKS
$18.1B
| $3.93M | ﹤0.01% |
113,500
-145,200
| -56% | -$5.32M |
|
3278
PUT
RingCentral
RNG
$5.39B
| $3.92M | ﹤0.01% |
34,100
-8,200
| -19% | -$945K |
|
|
CLDT
3279
Chatham Lodging
CLDT
$605M
| $3.91M | ﹤0.01% |
207,113
+73,917
| +55% | +$1.45M |
|
|
HT
3280
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $3.9M | ﹤0.01% |
236,119
-29,374
| -11% | -$520K |
|
|
HBI
3281
CALL
DELISTED
Hanesbrands
HBI
| $3.9M | ﹤0.01% |
226,500
+400
| +0.2% | +$6.89K |
|
3282
PUT
NRG Energy
NRG
$26.5B
| $3.9M | ﹤0.01% |
110,900
-66,700
| -38% | -$2.51M |
|
|
SC
3283
CALL
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $3.89M | ﹤0.01% |
162,500
+77,400
| +91% | +$1.72M |
|
3284
iShares MSCI USA Value Factor ETF
VLUE
$9.78B
| $3.89M | ﹤0.01% |
47,944
-5,966
| -11% | -$478K |
|
3285
CALL
HealthEquity
HQY
$8.76B
| $3.89M | ﹤0.01% |
59,500
+14,000
| +31% | +$974K |
|
3286
Voyager Therapeutics
VYGR
$201M
| $3.88M | ﹤0.01% |
+142,711
| New | +$3.27M |
|
|
TARO
3287
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3.88M | ﹤0.01% |
45,433
+3,958
| +10% | +$391K |
|
3288
AMN Healthcare
AMN
$1.34B
| $3.88M | ﹤0.01% |
71,507
-32,601
| -31% | -$1.65M |
|
3289
PUT
Applied Optoelectronics
AAOI
$12.7B
| $3.88M | ﹤0.01% |
376,900
+188,800
| +100% | +$2.02M |
|
3290
Amkor Technology
AMKR
$14.7B
| $3.87M | ﹤0.01% |
519,251
+223,827
| +76% | +$1.75M |
|
|
PDCO
3291
DELISTED
Patterson Companies, Inc.
PDCO
| $3.87M | ﹤0.01% |
169,194
-204,194
| -55% | -$4.54M |
|
3292
Adtran
ADTN
$684M
| $3.87M | ﹤0.01% |
253,879
-66,404
| -21% | -$1.06M |
|
|
POLY
3293
CALL
DELISTED
Plantronics, Inc.
POLY
| $3.87M | ﹤0.01% |
104,500
-102,200
| -49% | -$4.74M |
|
3294
CALL
Vishay Intertechnology
VSH
$5.38B
| $3.86M | ﹤0.01% |
233,800
-24,200
| -9% | -$427K |
|
3295
Pultegroup
PHM
$24.8B
| $3.86M | ﹤0.01% |
122,081
-199,626
| -62% | -$6.23M |
|
3296
Qorvo
QRVO
$8.66B
| $3.86M | ﹤0.01% |
57,895
+12,821
| +28% | +$891K |
|
|
SINA
3297
PUT
DELISTED
Sina Corp
SINA
| $3.86M | ﹤0.01% |
89,400
-7,500
| -8% | -$393K |
|
3298
VanEck India Growth Leaders ETF
GLIN
$92.9M
| $3.85M | ﹤0.01% |
101,574
+86,616
| +579% | +$3.55M |
|
|
KSU
3299
DELISTED
Kansas City Southern
KSU
| $3.85M | ﹤0.01% |
31,640
-20,436
| -39% | -$2.45M |
|
|
STMP
3300
DELISTED
Stamps.com, Inc.
STMP
| $3.85M | ﹤0.01% |
85,141
-134,366
| -61% | -$7.7M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.